ジェネリック注射剤市場レポート治療領域別(がん、麻酔、抗感染症、非経口栄養、循環器)、容器別(バイアル、アンプル、プレミックス、プレフィルドシリンジ)、流通チャネル別(病院、小売薬局)、地域別 2025-2033

ジェネリック注射剤市場レポート治療領域別(がん、麻酔、抗感染症、非経口栄養、循環器)、容器別(バイアル、アンプル、プレミックス、プレフィルドシリンジ)、流通チャネル別(病院、小売薬局)、地域別 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A16000

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Generic Drug Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Market Breakup by Region
    5.4    Market Forecast
    5.5    Major Players
6   Global Generic Drug Delivery Market
    6.1    Oral
    6.2    Injectables
    6.3    Dermal/Topical
    6.4    Inhalers
7   Global Generic Injectables Market
    7.1    Market Overview
    7.2    Market Performance
    7.3    Impact of COVID-19
    7.4    Market Breakup by Region
    7.5    Market Breakup by Therapeutic Area
    7.6    Market Breakup by Container
    7.7    Market Breakup by Distribution Channel
    7.8    Market Forecast
    7.9    SWOT Analysis
        7.9.1 Overview
        7.9.2 Strengths
        7.9.3 Weaknesses
        7.9.4 Opportunities
        7.9.5 Threats
    7.10    Value Chain Analysis
    7.11    Porter’s Five Forces Analysis
        7.11.1 Overview
        7.11.2 Bargaining Power of Buyers
        7.11.3 Bargaining Power of Suppliers
        7.11.4 Degree of Competition
        7.11.5 Threat of New Entrants
        7.11.6 Threat of Substitutes
    7.12    Key Market Drivers and Success Factors
8   Global Generic Injectables Market: Performance of Key Regions
    8.1 North America
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2 Europe
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3 Asia
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4 Latin America
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5 Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market by Therapeutic Area
    9.1 Oncology
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2 Anaesthesia
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3 Anti-infectives
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4 Parenteral Nutrition
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5 Cardiovascular
        9.5.1 Market Trends
        9.5.2 Market Forecast
10   Market by Container
     10.1 Vials
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2 Ampoules
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3 Premix
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4 Prefilled Syringes
        10.4.1 Market Trends
        10.4.2 Market Forecast
11  Market by Distribution Channel
    11.1 Hospitals
        11.1.1 Market Trends
        11.1.2 Market Forecast
    11.2 Retail Pharmacy 
        11.2.1 Market Trends
        11.2.2 Market Forecast
12  Global Generic Injectables Market: Competitive Landscape
    12.1    Market Structure
    12.2    Market Breakup by Key Players
13  Generic Injectables Manufacturing Process
    13.1    Product Overview
    13.2    Detailed Process Flow (Injectables)
    13.3    Various Types of Unit Operations Involved
    13.4    Mass Balance and Raw Material Requirements
14  Project Details, Requirements and Costs Involved
    14.1    Land Requirements and Expenditures
    14.2    Construction Requirements and Expenditures
    14.3    Plant Machinery
    14.4    Machinery Pictures
    14.5    Raw Material Requirements and Expenditures
    14.6    Packaging Requirements and Expenditures
    14.7    Transportation Requirements and Expenditures
    14.8    Utility Requirements and Expenditures
    14.9    Manpower Requirements and Expenditures
    14.10   Other Capital Investments
15  Loans and Financial Assistance
16  Project Economics

    16.1    Capital Cost of the Project
    16.2    Techno-Economic Parameters
    16.3    Product Pricing and Margins Across Various Levels of the Supply Chain
    16.4    Taxation and Depreciation
    16.5    Income Projections
    16.6    Expenditure Projections
    16.7    Financial Analysis
    16.8    Profit Analysis
17  Key Player Profiles
    17.1    Baxter International Inc.
        17.1.1 Company Overview
        17.1.2 Product Portfolio
        17.1.3 Financials
        17.1.4 SWOT Analysis
    17.2    Fresenius Kabi AG
        17.2.1 Company Overview
        17.2.2 Product Portfolio
        17.2.3 Financials
        17.2.4 SWOT Analysis
    17.3    Hikma Pharmaceuticals plc
        17.3.1 Company Overview
        17.3.2 Product Portfolio
        17.3.3 Financials
        17.3.4 SWOT Analysis
    17.4    Pfizer Inc.
        17.4.1 Company Overview
        17.4.2 Product Portfolio
        17.4.3 Financials
        17.4.4 SWOT Analysis
    17.5    Sagent Pharmaceuticals Inc. (Nichi-Iko Pharmaceutical Co. Ltd.)
        17.5.1 Company Overview
        17.5.2 Product Portfolio
        17.5.3 Financials
        17.5.4 SWOT Analysis
    17.6    Sandoz International GmbH (Novartis International AG)
        17.6.1 Company Overview
        17.6.2 Product Portfolio
        17.6.3 Financials
        17.6.4 SWOT Analysis
    17.7    Sanofi S.A.
        17.7.1 Company Overview
        17.7.2 Product Portfolio
        17.7.3 Financials
        17.7.4 SWOT Analysis

ジェネリック注射剤市場レポート治療領域別(がん、麻酔、抗感染症、非経口栄養、循環器)、容器別(バイアル、アンプル、プレミックス、プレフィルドシリンジ)、流通チャネル別(病院、小売薬局)、地域別 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials